查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1654659

全球新生兒呼吸器市場 - 2025 至 2033 年

Global Neonatal Ventilators Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 205 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球新生兒呼吸器市場規模達到 4.3906 億美元，預計到 2033 年將達到 7.0854 億美元，在 2025-2033 年預測期內的複合年成長率為 5.4%。

新生兒呼吸器是一種旨在為新生兒，特別是早產兒或患有呼吸系統疾病的新生兒提供呼吸支援的醫療設備。它們透過輸送氧氣和去除二氧化碳來控制呼吸過程，確保充分的氣體交換。這些呼吸器是根據新生兒獨特的生理需求而量身定做的，提供精確的壓力、容量和流量控制，以最大限度地減少肺部損傷並最大限度地提供呼吸支持。它們通常用於新生兒重症監護室，治療呼吸窘迫症候群和呼吸暫停等病症。

市場動態：

促進因素與約束因素

早產盛行率不斷上升

由於早產的增加，全球新生兒呼吸器市場正在成長，早產常常導致呼吸窘迫症候群和早產呼吸暫停等併發症。早產兒佔所有活產嬰兒的 10%，需要專門的呼吸器來維持生命。人們對新生兒健康的認知不斷提高，以及降低死亡率的需要，凸顯了新生兒呼吸器在控制日益加重的早產負擔方面的重要性。

例如，根據歐洲新生兒護理基金會（EFCNI）的數據，全球每年約有 1,340 萬名嬰兒早產，併發症是全球 5 歲以下兒童死亡的主要原因。許多倖存者面臨終身殘疾，包括學習障礙和視力和聽力問題。 184個國家的早產率從5％到18％不等。存活率很低，在低收入地區，出生時孕齡不超過 32 週的嬰兒有一半因缺乏基本照護而死亡。在歐洲，早產是新生兒死亡的兩大原因之一，佔兒童後期死亡總數的一半以上。

呼吸器相關成本高昂

全球新生兒呼吸器市場因其高成本而受到阻礙，這需要大量的投資和維護，這對中低收入國家的醫療機構來說是一個挑戰。這種經濟負擔也限制了這些設備在資源受限環境中的採用，阻礙了市場成長。例如，新生兒呼吸器的成本約為 15,000 至 20,000 美元，這是預測期內阻礙市場發展的主要因素之一。

目錄

第 1 章：方法與範圍

第 2 章：定義與概述

第 3 章：執行摘要

第 4 章：動態

  • 影響因素
    • 驅動程式
      • 早產盛行率不斷上升
    • 限制
      • 呼吸器相關成本高昂
    • 機會
    • 影響分析

第5章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析

第 6 章：依產品類型

  • 侵入式呼吸機
  • 非侵入性呼吸機

第 7 章：透過移動性

  • 重症監護系統
  • 攜帶式系統

第 8 章：按技術

  • 機械呼吸器
  • 高頻呼吸機
  • 容量定向呼吸機
  • 混合呼吸機

第 9 章：按模式

  • 壓力模式通氣
  • 聯合模式通氣
  • 容量模式通氣
  • 其他模式

第 10 章：按最終用戶

  • 醫院
  • 新生兒門診
  • 門診手術中心

第 11 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 12 章：競爭格局

  • 競爭格局
  • 市場定位/佔有率分析
  • 併購分析

第 13 章：公司簡介

  • Air Liquide
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售量
      • 產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 關鍵進展
      • 合併與收購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT 分析
  • Breas Medical
  • Dragerwerk AG & Co. KGaA
  • GE Healthcare
  • HAMILTON MEDICAL
  • Getinge Group
  • Medtronic plc
  • ICU Medical
  • Vyaire Medical
  • ResMed
  • Similar data will be provided for each market player.
  • ACUTRONIC 醫療系統股份公司
    • 管道產品描述
    • 產品關鍵績效指標 (KPI)
    • 主要活動
    • 市場進入時間表
    • 產品滲透率
    • 銷售估計和預測
  • Vyaire 醫療公司
  • 德爾格股份公司
  • 將為每個市場參與者提供類似的資料。

第 14 章：附錄

簡介目錄
Product Code: MD7483

The Global Neonatal Ventilators Market reached US$ 439.06 million in 2024 and is expected to reach US$ 708.54 million by 2033, growing at a CAGR of 5.4% during the forecast period 2025-2033.

Neonatal ventilators are medical devices designed to provide respiratory support to newborns, especially those with preterm infants or respiratory disorders. They control the breathing process by delivering oxygen and removing carbon dioxide, ensuring adequate gas exchange. These ventilators are tailored to meet newborns' unique physiological needs, offering precise pressure, volume, and flow controls to minimize lung injury and maximize respiratory support. They are commonly used in neonatal intensive care units to manage conditions like respiratory distress syndrome and apnea.

Market Dynamics: Drivers & Restraints

Increasing Prevalence of Preterm Births

The global neonatal ventilators market is growing due to the rise in preterm births, which often result in complications like respiratory distress syndrome and apnea of prematurity. Preterm infants, who account for 10% of all live births, require specialized ventilators for life-saving support. The increasing awareness of neonatal health and the need to reduce mortality rates underscore the importance of neonatal ventilators in managing the growing burden of preterm births.

For instance, according to The European Foundation for the Care of Newborn Infants (EFCNI), Around 13.4 million babies are born preterm annually globally, with complications being the main cause of global under-5 deaths. Many survivors face lifetime disabilities, including learning disabilities and visual and hearing problems. Preterm birth rates range from 5% to 18% in 184 countries. Survival rates are stark, with low-income settings experiencing half of babies born at or below 32 weeks dying due to lack of basic care. In Europe, preterm birth is one of the two leading causes of neonatal mortality and accounts for over half of all deaths in later childhood.

High Cost associated with the Ventilators

The global market for neonatal ventilators is hindered by their high cost, which requires substantial investment and maintenance, which can be challenging for healthcare facilities in low- and middle-income countries. This financial burden also limits the adoption of these devices in resource-constrained settings, hindering market growth. For instance, the approx cost of neonatal ventilators costs around US$ 15000-US$ 20,000 which is one of the major factor that hinders the market during the forecast period.

Segment Analysis

The global Neonatal Ventilators Market is segmented based on Product Type, Mobility, Technology, Mode, End User and Region.

Product Type:

Invasive Ventilators segment is expected to dominate the Neonatal Ventilators market share

The invasive ventilators segment holds a major portion of the Neonatal Ventilators market share and is expected to continue to hold a significant portion of the Neonatal Ventilators market share during the forecast period.

Invasive ventilators are essential in the global neonatal ventilators market, particularly for newborns with severe respiratory conditions. They insert a tube into the infant's airway, typically through the trachea, to ensure a secure and controlled airway for effective ventilation. They are used in critical situations like respiratory distress syndrome, where non-invasive methods may not be sufficient. Invasive ventilators provide precise control over air pressure, volume, and oxygen delivery, essential for managing neonates' delicate lungs. The demand for these ventilators continues to grow in neonatal intensive care units worldwide.

For instance, in November 2024, Inspiration Healthcare Group has launched the SLE1500, a compact respiratory support system designed for the smallest and most vulnerable neonatal patients. This invasive ventilation mode is designed to protect their fragile lungs and is part of their specialist neonatal ventilator range.

End Users:-

Hospitals segment is the fastest-growing segment in Neonatal Ventilators market share

The hospitals segment is the fastest-growing segment in the Neonatal Ventilators market share and is expected to hold the market share over the forecast period.

The global neonatal ventilators market is largely driven by hospitals, particularly neonatal intensive care units (NICUs), which provide specialized care for newborns with critical health issues. The adoption of advanced ventilator technologies, coupled with a focus on improving neonatal outcomes and reducing mortality rates, drives market demand. The increasing number of NICUs and improvements in hospital infrastructure also contribute to market growth.

For instance, in January 2025, Gleneagles Hospitals in Parel, Mumbai has expanded its obstetrics services and introduced a new Neonatal Intensive Care Unit (NICU) to improve maternal and newborn healthcare. The NICU, equipped with four beds, is designed for neonates up to 30 days old, particularly those born prematurely or with critical conditions. It features advanced ventilators, warmers, and neurodevelopment assessment tools to manage respiratory distress, infections, and growth concerns. A team of trained pediatricians and nurses provides 24x7 monitoring and expert care.

Geographical Analysis

North America is expected to hold a significant position in the Neonatal Ventilators market share

North America holds a substantial position in the Neonatal Ventilators market and is expected to hold most of the market share due to rising preterm births, advancements in care technologies, and high healthcare expenditure. The region's well-established healthcare infrastructure and government initiatives for neonatal health, along with increased awareness and adoption of innovative ventilator technologies by leading facilities, support market expansion.

For instance, according to March of Dimes' 2024 Report Card reveals a high US preterm birth rate of 10.4%, with significant disparities among racial and ethnic groups. The report highlights the need for improved maternal and infant health outcomes and emphasizes the urgent need to prioritize the health of mothers and babies.

Europe is growing at the fastest pace in the Neonatal Ventilators market

Europe holds the fastest pace in the Neonatal Ventilators market and is expected to hold most of the market share due to government initiatives, product launches, strong healthcare policies, investment in medical device research, and key market players. The growing awareness of advanced ventilatory support and a focus on reducing neonatal mortality rates contributes to market growth in Europe.

For instance, in December 2024, Europlaz, a UK-based company, has developed a medical innovation that could improve neonatal care and save lives. The Chelmsford-based company believes that ventilator manufacturers should consider switching to this neonatal flow sensor to save lives, reduce NHS costs, and avoid costly litigation. The innovation has been developed for years.

Competitive Landscape

The major global players in the neonatal ventilators market include Air Liquide, Breas Medical, Dragerwerk AG & Co. KGaA, GE Healthcare, HAMILTON MEDICAL, Getinge Group, Medtronic plc, ICU Medical, Vyaire Medical, ResMed and among others.

Key Developments

  • In September 2024, The Fritz Stephan 'STEPHANIE' Neonatal & Infant Ventilator, designed to meet neonatal and paediatric requirements, have been officially launched at the Association of Anaesthetists Annual Congress. The new STEPHANIE, bringing 50 years of expertise, offers unique performance and a modular design structure that simplifies everyday hospital life and offers added flexibility. It is fully equipped to prepare for the ventilation of newborns and preterm infants, showcasing how clinical experience and technical expertise can create outstanding products.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global Neonatal Ventilators market report delivers a detailed analysis with 78 key tables, more than 72 visually impactful figures, and 205 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Mobility & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Mobility
  • 3.3. Snippet by Technology
  • 3.4. Snippet by Mode
  • 3.5. Snippet by End User
  • 3.6. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Prevalence of Preterm Births
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost associated with the Ventilators
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Invasive Ventilators*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Non-Invasive Ventilators

7. By Mobility

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 7.1.2. Market Attractiveness Index, By Mobility
  • 7.2. Intensive Care System*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Portable System

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology
  • 8.2. Mechanical ventilators*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. High frequency ventilators
  • 8.4. Volume targeted ventilators
  • 8.5. Hybrid ventilators

9. By Mode

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode
    • 9.1.2. Market Attractiveness Index, By Mode
  • 9.2. Pressure Mode Ventilation*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Combined Mode Ventilation
  • 9.4. Volume Mode Ventilation
  • 9.5. Other Modes

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Neonatal Clinics
  • 10.4. Ambulatory Surgical Centers

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.8.1. U.S.
      • 11.2.8.2. Canada
      • 11.2.8.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.8.1. Germany
      • 11.3.8.2. U.K.
      • 11.3.8.3. France
      • 11.3.8.4. Spain
      • 11.3.8.5. Italy
      • 11.3.8.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.8.1. Brazil
      • 11.4.8.2. Argentina
      • 11.4.8.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.8.1. China
      • 11.5.8.2. India
      • 11.5.8.3. Japan
      • 11.5.8.4. South Korea
      • 11.5.8.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode
    • 11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

Key Market Players

  • 13.1. Air Liquide*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio
      • 13.1.2.1. Product Description
      • 13.1.2.2. Product Key Performance Indicators (KPIs)
      • 13.1.2.3. Historic and Forecasted Product Sales
      • 13.1.2.4. Product Sales Volume
    • 13.1.3. Financial Overview
      • 13.1.3.1. Company Revenue's
      • 13.1.3.2. Geographical Revenue Shares
      • 13.1.3.3. Revenue Forecasts
    • 13.1.4. Key Developments
      • 13.1.4.1. Mergers & Acquisitions
      • 13.1.4.2. Key Product Development Activities
      • 13.1.4.3. Regulatory Approvals etc.
    • 13.1.5. SWOT Analysis
  • 13.2. Breas Medical
  • 13.3. Dragerwerk AG & Co. KGaA
  • 13.4. GE Healthcare
  • 13.5. HAMILTON MEDICAL
  • 13.6. Getinge Group
  • 13.7. Medtronic plc
  • 13.8. ICU Medical
  • 13.9. Vyaire Medical
  • 13.10. ResMed
  • Similar data will be provided for each market player.

Emerging Market Players

  • 13.11. ACUTRONIC Medical Systems AG*
    • 13.11.1. Pipeline Products Description
    • 13.11.2. Product Key Performance Indicators (KPIs)
    • 13.11.3. Key Activities
    • 13.11.4. Market Entry Timelines
    • 13.11.5. Product Penetration Rate
    • 13.11.6. Sales Estimation and Projections
  • 13.12. Vyaire Medical, Inc
  • 13.13. Dragerwerk AG & Co. KGaA
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1 About Us and Services
  • 14.2 Contact Us